Arthritis Research UK
|This article does not cite any references or sources. (January 2012)|
ARC, which had been founded originally as the Empire Rheumatism Council in 1936, changed its name to Arthritis Research UK  in 2010 as part of a drive to raise the profile of Arthritis research and the organisation itself. It has also reduced the potential for confusion with a plethora of other charitable groups using the 'arc' initials.
About Arthritis Research UK
Arthritis Research UK is a United Kingdom based Charity, campaigning and working in the fight against arthritis. Arthritis Research UK was founded in 1936. Arthritis Research UK funds three research institutes focused on beating arthritis: Arthritis Research UK Pain Centre, The Kennedy Institute of Rheumatology and The Arthritis Research UK Epidemiology Unit (EU).
Dr Stewart Adams, discoverer of Ibuprofen, opened Arthritis Research UK Pain Centre. The centre, which is based in Nottingham, aims to understand pain and to come up with more effective ways of dealing with it.
The Arthritis Research UK Epidemiology Unit (EU) is funded at the University of Manchester and sits within the School of Medicine – Research School of Translational Medicine, Epidemiology Research Group.
Research has shown that 10 million people in the UK are affected by arthritis. Arthritis Research UK is working to help them to remain active by funding research, campaigning and providing information for patients, the public and health professionals.
Arthritis Research UK’s vision is a future free from arthritis.
Arthritis Research UK Mission Statement
Arthritis Research UK’s mission statement is to reduce the pain and disability resulting from arthritis by:
- Funding research into the cause, treatment and cure of arthritis and translating the results of that research to benefit patients
- Educating and informing the general public, patients and health professionals on all aspects of arthritis
- Campaigning for treatment and support for all those living with arthritis
- Working in partnership with others to make a greater difference for people with arthritis.
The Arthritis Research UK research committee considers around 400 applications for funding per year. The medical research provides answers about the causes of arthritis, effective treatment, and ultimately the cure for all arthritis and musculoskeletal conditions.
Arthritis Research UK has been awarded for:
- Developing anti-TNF therapy for rheumatoid arthritis beyond existing treatments
- Identifying the genes linked to the disease in patients with osteoarthritis
- Developing longer-lasting and durable prostheses, and researching the causes, effects and treatments of infections in joint replacements
- Improving the treatment of brittle bone disease in children
- Developing tissue engineering techniques in osteoarthritis by using patients' own cartilage
- Looking at ways of better targeting drug treatment in arthritis in children and teenagers
- Examining the role of therapies such as acupuncture and yoga, on osteoarthritis and back pain